News

We received an investment from Kyoto University Innovation Capital Co., Ltd. and a press release was made. It was also published in the Nihon Keizai Shimbun (April 6th).

Kyoto University based drug discovery startup BTB Drug Development Research Center (Kyoto City) has raised \100 million from venture capital firms associated with Kyoto University. This will be used for drug research and development. BTB are developing painkillers that can reduce postoperative pain, and will simultaneously begin clinical trials within Japan and overseas in FY2022.

The another project has been selected for drug discovery support promotion project at 2021 - Practical application support project for the drugs of rare disease by the Japan Agency for Medical Development(AMED). Title: Development of a new drug for the splicing mutant genetic patients.

The project has been selected for the 5th Call for Applications (ViCLE Practical Application Development Type) for the Creation of Innovative Core for Medical Research and Development (CiCLE) by the Japan Agency for Medical Development (AMED). Title: Development of ENDOPIN, a novel non-NSAIDS/non-opioid painkiller

The website of BTB Drug Development Research Center has been updated.

The website of BTB Drug Development Research Center has been launched.